Sartorius AG (XTER:SRT3) Net Income From Continuing Operations : €213 Mil (TTM As of Mar. 2025)

View and export this data going back to 1990. Start your Free Trial

What is Sartorius AG Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Sartorius AG's net income from continuing operations for the three months ended in Mar. 2025 was €100 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was €213 Mil.

Sartorius AG Net Income From Continuing Operations Historical Data

The historical data trend for Sartorius AG's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Net Income From Continuing Operations Chart

Sartorius AG Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income From Continuing Operations

Get a 7-Day Free Trial

424.75

668.40

1,181.70

386.70

186.80

Sartorius AG Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income From Continuing Operations	Get a 7-Day Free Trial															73.50	52.50	30.80	30.00	99.50

Sartorius AG Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €213 Mil.

Sartorius AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (XTER:SRT3) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

SOAGY:USA SSSGY:USA SARTF:USA 1SRT:Italy 1SRT3:Italy SRT3d:UK 0NIR:UK 0NIQ:UK SRT3:Bulgaria SATG:Austria SRT3:Austria

Address

Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079

Website

https://www.sartorius.com

Sartorius AG is a leading provider of bioprocessing solutions. Its bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology. Its laboratory products and services division offers a wide range of products for laboratory use, including scales, pipettes, and filtration equipment. As of 2024, the bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 72% ownership and 83% voting control. The business is geographically diverse, with revenue across Europe, Middle East, and Africa (41% of 2024 sales), the Americas (36%), and Asia-Pacific (23%). We estimate China revenue to be around 10%.

Executives

Dr. Lothar Ewald Kappich	Supervisory Board
Dr. Joachim Kreuzburg	Board of Directors

Sartorius AG Headlines

No Headlines